Please login to the form below

Not currently logged in
Email:
Password:

ConfometRx

This page shows the latest ConfometRx news and features for those working in and with pharma, biotech and healthcare.

UCB signs research deal for novel neuroscience drugs

UCB signs research deal for novel neuroscience drugs

The Belgium-based biopharma firm is collaborating with ConfometRx, a California-based company that was co-founded by Stanford University professor and Nobel Prize winner Brian Kobilka. ... The two-year multi-target agreement will see UCB and ConfometRx

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...

Infographics